{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:26:24Z","timestamp":1787243184916,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R191-2015-1605"],"award-info":[{"award-number":["R191-2015-1605"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R223-2016-849"],"award-info":[{"award-number":["R223-2016-849"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novo Nordisk Foundation BRIDGE Translational Excellence Programme","award":["NNF20SA0064340"],"award-info":[{"award-number":["NNF20SA0064340"]}]},{"name":"EU Horizon 2020 Research and Innovation Programme, Marie Sklodowska-Curie DISCOVER grant","award":["10103491"],"award-info":[{"award-number":["10103491"]}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-6110-00658"],"award-info":[{"award-number":["DFF-6110-00658"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dysregulated interferon-alpha\/beta-receptor 1 (IFNAR1) signaling was recently identified to contribute to the development of sporadic Parkinson\u2019s disease (PD) into PD with Dementia (PDD). The molecular, cellular, and phenotypic impacts of brain IFNAR1 loss in aging have not been explored in vivo, which may reveal novel disease mechanisms and therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Single nuclei RNA sequencing (snRNA-seq), liquid chromatography tandem mass spectrometry (LC\u2013MS\/MS), functional metabolic mapping, flow cytometry, quantitative PCR (qPCR), in situ hybridization, immunofluorescence and immunohistochemistry, Western blotting, and behavior analyses were used to investigate the molecular, cellular, and phenotypic impacts of IFNAR1 loss in vivo\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline IFNAR1 expression varies among major brain cell types, including neurons and astrocytes, and is differentially affected in PD and Lewy Body Dementia patients compared to unaffected controls. Neuron- and astrocyte-specific transcriptomic and proteomic alterations in\n                      <jats:italic>Ifnar1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2013\/\u2013<\/jats:italic>\n                      <\/jats:sup>\n                      mice implicate mitochondrial defects, defective mitophagy, and synergistic dysfunctional neurotransmission upon IFNAR1 loss, leading to glucose hypermetabolism measured by functional metabolic analysis. Consequently,\n                      <jats:italic>Ifnar1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2013\/\u2013<\/jats:italic>\n                      <\/jats:sup>\n                      mice exhibited PDD-like pathogenesis, including dopaminergic cell loss in the substantia nigra, cortical neurodegeneration, Lewy-body-like inclusions, neuroinflammation, and progressive PDD-like behavior deficits. Brain cell-specific IFNAR1 loss examined in vivo revealed delayed but distinct development of PDD-like phenotypes, where neuropathology, motor, and cognitive behavior deficits were recapitulated only in mice lacking neuronal IFNAR1, and behavior resembling neuropsychiatric abnormalities recapitulated only in mice lacking astrocytic IFNAR1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IFNAR1 plays a crucial role in brain and mitochondrial homeostasis, loss of which results in neurodegeneration and neuropathology resembling PDD. Differential neuropathology and behavioral outcomes upon neuronal vs astrocytic IFNAR1 loss emphasizes a need for understanding neurodegenerative pathophysiology in cell-specific contexts.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      Not applicable as the study does not include a clinical trial.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-026-01257-8","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:43:34Z","timestamp":1780325014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct and combined interferon-\u0251\/\u03b2-receptor-1 loss in neurons and astrocytes disrupt brain energy metabolism and drive Parkinsonian dementia"],"prefix":"10.1186","volume":"33","author":[{"given":"Erika B.","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zala","family":"Zebec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cisquella-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Lundstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens V.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippa L.","family":"Qvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil W.","family":"Westi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Jimenez-Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Riera-Ponsati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Tresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Loreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca I.","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels H.","family":"Skotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Issazadeh-Navikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"6","key":"1257_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837\u201344.","journal-title":"Mov Disord"},{"issue":"11","key":"1257_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","volume":"79","author":"M Petrou","year":"2012","unstructured":"Petrou M, Bohnen NI, M\u00fcller ML, Koeppe RA, Albin RL, Frey KA. A\u03b2-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 2012;79(11):1161\u20137.","journal-title":"Neurology"},{"issue":"1","key":"1257_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mds.26369","volume":"31","author":"N Shah","year":"2016","unstructured":"Shah N, Frey KA, M\u00fcller ML, Petrou M, Kotagal V, Koeppe RA, et al. Striatal and cortical \u03b2-amyloidopathy and cognition in Parkinson\u2019s Disease. Mov Disord. 2016;31(1):111\u20137.","journal-title":"Mov Disord"},{"issue":"24","key":"1257_CR4","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","volume":"95","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, et al. \u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology. 2020;95(24):e3257\u201368.","journal-title":"Neurology"},{"issue":"12","key":"1257_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/archneur.1992.00530360060019","volume":"49","author":"RF Peppard","year":"1992","unstructured":"Peppard RF, Martin WRW, Carr GD, Grochowski E, Schulzer M, Guttman M, et al. Cerebral glucose metabolism in Parkinson\u2019s Disease with and without dementia. Arch Neurol. 1992;49(12):1262\u20138.","journal-title":"Arch Neurol"},{"issue":"5","key":"1257_CR6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","volume":"35","author":"L Dunn","year":"2014","unstructured":"Dunn L, Allen GF, Mamais A, Ling H, Li A, Duberley KE, et al. Dysregulation of glucose metabolism is an early event in sporadic Parkinson\u2019s disease. Neurobiol Aging. 2014;35(5):1111\u20135.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1257_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","volume":"47","author":"SK Meles","year":"2020","unstructured":"Meles SK, Renken RJ, Pagani M, Teune LK, Arnaldi D, Morbelli S, et al. Abnormal pattern of brain glucose metabolism in Parkinson\u2019s disease: replication in three European cohorts. Eur J Nucl Med Mol Imaging. 2020;47(2):437\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"1257_CR8","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00259-018-4085-1","volume":"45","author":"D Blum","year":"2018","unstructured":"Blum D, la Foug\u00e8re C, Pilotto A, Maetzler W, Berg D, Reimold M, et al. Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2018;45(13):2387\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1257_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"key":"1257_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01207-w","author":"J Magalhaes","year":"2021","unstructured":"Magalhaes J, Tresse E, Ejlerskov P, Hu E, Liu Y, Marin A, et al. PIAS2-mediated blockade of IFN-\u03b2 signaling: a basis for sporadic Parkinson disease dementia. Mol Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41380-021-01207-w.","journal-title":"Mol Psychiatry"},{"key":"1257_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02251-4","author":"E Tresse","year":"2023","unstructured":"Tresse E, Marturia-Navarro J, Sew WQG, Cisquella-Serra M, Jaberi E, Riera-Ponsati L, et al. Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-023-02251-4.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1257_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.26209","volume":"90","author":"EB Villanueva","year":"2021","unstructured":"Villanueva EB, Tresse E, Liu Y, Duarte JN, Jimenez-Duran G, Ejlerskov P, et al. Neuronal TNF\u03b1, Not \u03b1-Syn, Underlies PDD-Like Disease Progression in IFN\u03b2-KO Mice. Ann Neurol. 2021;90(5):789\u2013807.","journal-title":"Ann Neurol"},{"issue":"2","key":"1257_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2015.08.069","volume":"163","author":"P Ejlerskov","year":"2015","unstructured":"Ejlerskov P, Hultberg JG, Wang J, Carlsson R, Ambjorn M, Kuss M, et al. Lack of neuronal IFN-beta-IFNAR causes Lewy Body- and Parkinson\u2019s disease-like dementia. Cell. 2015;163(2):324\u201339.","journal-title":"Cell"},{"issue":"7","key":"1257_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107666","volume":"31","author":"S Hosseini","year":"2020","unstructured":"Hosseini S, Michaelsen-Preusse K, Grigoryan G, Chhatbar C, Kalinke U, Korte M. Type I interferon receptor signaling in astrocytes regulates hippocampal synaptic plasticity and cognitive function of the healthy CNS. Cell Rep. 2020;31(7):107666.","journal-title":"Cell Rep"},{"issue":"7879","key":"1257_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03465-8","volume":"598","author":"TE Bakken","year":"2021","unstructured":"Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, et al. Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 2021;598(7879):111\u20139.","journal-title":"Nature"},{"issue":"5","key":"1257_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T, Abdulraouf A, Burris SJ, Langlieb J, Gazestani V, Nadaf NM, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci. 2022;25(5):588\u201395.","journal-title":"Nat Neurosci"},{"issue":"5","key":"1257_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","volume":"28","author":"M Prinz","year":"2008","unstructured":"Prinz M, Schmidt H, Mildner A, Knobeloch K-P, Hanisch U-K, Raasch J, et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 2008;28(5):675\u201386.","journal-title":"Immunity"},{"issue":"10","key":"1257_CR18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-06-027599","volume":"108","author":"E Kamphuis","year":"2006","unstructured":"Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006;108(10):3253\u201361.","journal-title":"Blood"},{"issue":"7","key":"1257_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.862101","volume":"15","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ, et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 2001;15(7):859\u201376.","journal-title":"Genes Dev"},{"issue":"6","key":"1257_CR20","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3095-08.2009","volume":"29","author":"C Gregorian","year":"2009","unstructured":"Gregorian C, Nakashima J, Le Belle J, Ohab J, Kim R, Liu A, et al. Pten deletion in adult neural stem\/progenitor cells enhances constitutive neurogenesis. J Neurosci. 2009;29(6):1874.","journal-title":"J Neurosci"},{"issue":"1","key":"1257_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-020-0109-1","volume":"6","author":"TH Reekes","year":"2020","unstructured":"Reekes TH, Higginson CI, Ledbetter CR, Sathivadivel N, Zweig RM, Disbrow EA. Sex specific cognitive differences in Parkinson disease. npj Park Dis. 2020;6(1):7.","journal-title":"npj Park Dis"},{"issue":"40","key":"1257_CR22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-Amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s Disease mutations: Potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129.","journal-title":"J Neurosci"},{"issue":"1","key":"1257_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13\u201324.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1257_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","volume":"84","author":"M Zarei","year":"2013","unstructured":"Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, et al. Cortical thinning is associated with disease stages and dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2013;84(8):875.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2\u20133","key":"1257_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, et al. The significance of \u03b1-synuclein, amyloid-\u03b2 and Tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis. 2014;13(2\u20133):154\u20136.","journal-title":"Neurodegener Dis"},{"key":"1257_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VMY, Trojanowski JQ. Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci. 2013;14:626.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"1257_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord. 2003;18(7):784\u201390.","journal-title":"Mov Disord"},{"issue":"6","key":"1257_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8(6):329\u201339.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1257_CR29","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1038\/s41467-020-18752-7","volume":"11","author":"U Pfisterer","year":"2020","unstructured":"Pfisterer U, Petukhov V, Demharter S, Meichsner J, Thompson JJ, Batiuk MY, et al. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis. Nat Commun. 2020;11(1):5038.","journal-title":"Nat Commun"},{"issue":"3","key":"1257_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nprot.2016.015","volume":"11","author":"SR Krishnaswami","year":"2016","unstructured":"Krishnaswami SR, Grindberg RV, Novotny M, Venepally P, Lacar B, Bhutani K, et al. Using single nuclei for RNA-seq to capture the transcriptome of postmortem neurons. Nat Protoc. 2016;11(3):499\u2013524.","journal-title":"Nat Protoc"},{"issue":"7","key":"1257_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-902.e21.","journal-title":"Cell"},{"issue":"8","key":"1257_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41592-019-0466-z","volume":"16","author":"N Barkas","year":"2019","unstructured":"Barkas N, Petukhov V, Nikolaeva D, Lozinsky Y, Demharter S, Khodosevich K, et al. Joint analysis of heterogeneous single-cell RNA-seq dataset collections. Nat Methods. 2019;16(8):695\u20138.","journal-title":"Nat Methods"},{"issue":"4","key":"1257_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: Computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8(4):281-91.e9.","journal-title":"Cell Syst"},{"issue":"5","key":"1257_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi L, Lun ATL, Morgan MD, Marioni JC. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018;36(5):421\u20137.","journal-title":"Nat Biotechnol"},{"issue":"43","key":"1257_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1257_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"1257_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16(1):169.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"1257_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1074\/mcp.O116.065136","volume":"16","author":"NA Kulak","year":"2017","unstructured":"Kulak NA, Geyer PE, Mann M. Loss-less nano-fractionator for high sensitivity, high coverage proteomics. Mol Cell Proteomics. 2017;16(4):694\u2013705.","journal-title":"Mol Cell Proteomics"},{"key":"1257_CR39","doi-asserted-by":"crossref","unstructured":"Brunner A-D, Thielert M, Vasilopoulou CG, Ammar C, Coscia F, Mund A, et al. Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation. bioRxiv. 2021:2020.12.22.423933.","DOI":"10.1101\/2020.12.22.423933"},{"key":"1257_CR40","doi-asserted-by":"crossref","unstructured":"Santos A, Cola\u00e7o AR, Nielsen AB, Niu L, Geyer PE, Coscia F, et al. Clinical knowledge graph integrates proteomics data into clinical decision-making. bioRxiv. 2020:2020.05.09.084897.","DOI":"10.1101\/2020.05.09.084897"},{"key":"1257_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14709","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Marin A, Ejlerskov P, Rasmussen LM, Prinz M, Issazadeh-Navikas S. Neuronal IFN-beta-induced PI3K\/Akt-FoxA1 signalling is essential for generation of FoxA1+Treg cells. Nat Commun. 2017;8:14709.","journal-title":"Nat Commun"},{"issue":"4","key":"1257_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.immuni.2016.04.005","volume":"44","author":"T Blank","year":"2016","unstructured":"Blank T, Detje CN, Spiess A, Hagemeyer N, Brendecke SM, Wolfart J, et al. Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment. Immunity. 2016;44(4):901\u201312.","journal-title":"Immunity"},{"issue":"n\/a","key":"1257_CR43","volume":"n\/a","author":"E Tresse","year":"2021","unstructured":"Tresse E, Riera-Ponsati L, Jaberi E, Sew WQG, Ruscher K, Issazadeh-Navikas S. IFN-\u03b2 rescues neurodegeneration by regulating mitochondrial fission via STAT5, PGAM5, and Drp1. EMBO J. 2021;n\/a(n\/a):e106868.","journal-title":"EMBO J"},{"issue":"4","key":"1257_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3746\/pnf.2021.26.4.408","volume":"26","author":"D Kwon","year":"2021","unstructured":"Kwon D, Kim C, Woo YK, Hwang JK. Inhibitory effects of Chrysanthemum (Chrysanthemum morifolium Ramat.) extract and its active compound Isochlorogenic Acid A on sarcopenia. Prev Nutr Food Sci. 2021;26(4):408\u201316.","journal-title":"Prev Nutr Food Sci"},{"key":"1257_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134334","volume":"708","author":"AR Burmeister","year":"2019","unstructured":"Burmeister AR, Johnson MB, Marriott I. Murine astrocytes are responsive to the pro-inflammatory effects of IL-20. Neurosci Lett. 2019;708:134334.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1257_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20889-y","volume":"12","author":"A Jana","year":"2022","unstructured":"Jana A, Wang X, Leasure JW, Magana L, Wang L, Kim YM, et al. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer\u2019s disease. Sci Rep. 2022;12(1):16488.","journal-title":"Sci Rep"},{"issue":"11","key":"1257_CR47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41419-021-04237-y","volume":"12","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Skotte NH, Christensen SK, Polli FS, Shabani M, Markussen KH, et al. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer\u2019s disease. Cell Death Dis. 2021;12(11):954.","journal-title":"Cell Death Dis"},{"issue":"7","key":"1257_CR48","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","volume":"23","author":"NH Skotte","year":"2018","unstructured":"Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, N\u00f8rrem\u00f8lle A, et al. Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism. Cell Rep. 2018;23(7):2211\u201324.","journal-title":"Cell Rep"},{"key":"1257_CR49","doi-asserted-by":"crossref","unstructured":"Andersen JV, Jakobsen E, Westi EW, Lie MEK, Voss CM, Aldana BI, et al. Extensive astrocyte metabolism of \u03b3-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex. Glia. 2020.","DOI":"10.1002\/glia.23872"},{"key":"1257_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106145","volume":"182","author":"EW Westi","year":"2023","unstructured":"Westi EW, Andersen JV, Aldana BI. Using stable isotope tracing to unravel the metabolic components of neurodegeneration: focus on neuron-glia metabolic interactions. Neurobiol Dis. 2023;182:106145.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1257_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/hmg\/dds397","volume":"22","author":"AL Southwell","year":"2013","unstructured":"Southwell AL, Warby SC, Carroll JB, Doty CN, Skotte NH, Zhang W, et al. A fully humanized transgenic mouse model of Huntington disease. Hum Mol Genet. 2013;22(1):18\u201334.","journal-title":"Hum Mol Genet"},{"key":"1257_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-61779-313-4_7","volume-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests","author":"BA Samuels","year":"2011","unstructured":"Samuels BA, Hen R. Novelty-Suppressed Feeding in the Mouse. In: Gould TD, editor. Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests, vol. II. Totowa, NJ: Humana Press; 2011. p. 107\u201321."},{"issue":"5634","key":"1257_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301(5634):805\u20139.","journal-title":"Science"},{"issue":"7","key":"1257_CR54","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"M-Y Liu","year":"2018","unstructured":"Liu M-Y, Yin C-Y, Zhu L-J, Zhu X-H, Xu C, Luo C-X, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686\u201398.","journal-title":"Nat Protoc"},{"issue":"43","key":"1257_CR55","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease. J Neurosci. 2009;29(43):13589\u2013602.","journal-title":"J Neurosci"},{"issue":"7","key":"1257_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41579-018-0020-5","volume":"16","author":"Y-C Perng","year":"2018","unstructured":"Perng Y-C, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16(7):423\u201339.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"1257_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.chom.2016.02.003","volume":"19","author":"V Castiglia","year":"2016","unstructured":"Castiglia V, Piersigilli A, Ebner F, Janos M, Goldmann O, Damb\u00f6ck U, et al. Type I interferon signaling prevents IL-1\u03b2-driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue. Cell Host Microbe. 2016;19(3):375\u201387.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"1257_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","volume":"16","author":"DB Lester","year":"2010","unstructured":"Lester DB, Rogers TD, Blaha CD. Acetylcholine\u2013dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010;16(3):137\u201362.","journal-title":"CNS Neurosci Ther"},{"key":"1257_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnsyn.2015.00003","volume":"7","author":"G Born","year":"2015","unstructured":"Born G, Grayton HM, Langhorst H, Dudanova I, Rohlmann A, Woodward BW, et al. Genetic targeting of NRXN2 in mice unveils role in excitatory cortical synapse function and social behaviors. Front Synaptic Neurosci. 2015;7:3.","journal-title":"Front Synaptic Neurosci."},{"issue":"4","key":"1257_CR60","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.27614","volume":"34","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, et al. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson\u2019s disease. Mov Disord. 2019;34(4):460\u20138.","journal-title":"Mov Disord"},{"issue":"3","key":"1257_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02261-4","volume":"141","author":"DC Hondius","year":"2021","unstructured":"Hondius DC, Koopmans F, Leistner C, Pita-Illobre D, Peferoen-Baert RM, Marbus F, et al. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease. Acta Neuropathol. 2021;141(3):341\u201358.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1257_CR62","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1038\/tp.2014.35","volume":"4","author":"A Miyashita","year":"2014","unstructured":"Miyashita A, Hatsuta H, Kikuchi M, Nakaya A, Saito Y, Tsukie T, et al. Genes associated with the progression of neurofibrillary tangles in Alzheimer\u2019s disease. Transl Psychiatry. 2014;4(6):e396.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"1257_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005471","volume":"4","author":"A Parcellier","year":"2009","unstructured":"Parcellier A, Tintignac LA, Zhuravleva E, Dummler B, Brazil DP, Hynx D, et al. The carboxy-terminal modulator protein (CTMP) regulates mitochondrial dynamics. PLoS ONE. 2009;4(5):e5471.","journal-title":"PLoS ONE"},{"issue":"4","key":"1257_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cellsig.2009.01.016","volume":"21","author":"A Parcellier","year":"2009","unstructured":"Parcellier A, Tintignac LA, Zhuravleva E, Cron P, Schenk S, Bozulic L, et al. Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. Cell Signal. 2009;21(4):639\u201350.","journal-title":"Cell Signal"},{"key":"1257_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104810","volume":"140","author":"OA Ojiakor","year":"2020","unstructured":"Ojiakor OA, Rylett RJ. Modulation of sodium-coupled choline transporter CHT function in health and disease. Neurochem Int. 2020;140:104810.","journal-title":"Neurochem Int"},{"issue":"11","key":"1257_CR66","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1091\/mbc.E14-08-1310","volume":"26","author":"F Jaudon","year":"2015","unstructured":"Jaudon F, Raynaud F, Wehrl\u00e9 R, Bellanger J-M, Doulazmi M, Vodjdani G, et al. The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. Mol Biol Cell. 2015;26(11):2112\u201327.","journal-title":"Mol Biol Cell"},{"issue":"42","key":"1257_CR67","doi-asserted-by":"publisher","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","volume":"111","author":"YC Wong","year":"2014","unstructured":"Wong YC, Holzbaur EL. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A. 2014;111(42):E4439\u201348.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1257_CR68","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1093\/brain\/awac313","volume":"145","author":"D Imberechts","year":"2022","unstructured":"Imberechts D, Kinnart I, Wauters F, Terbeek J, Manders L, Wierda K, et al. DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy. Brain. 2022;145(12):4368\u201384.","journal-title":"Brain"},{"issue":"7565","key":"1257_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309\u201314.","journal-title":"Nature"},{"issue":"1","key":"1257_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","volume":"60","author":"JM Heo","year":"2015","unstructured":"Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60(1):7\u201320.","journal-title":"Mol Cell"},{"issue":"2","key":"1257_CR71","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnc.15811","volume":"166","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A. Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission - the essential roles of astrocytes. J Neurochem. 2023;166(2):109\u201337.","journal-title":"J Neurochem"},{"issue":"8","key":"1257_CR72","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/jcbfm.2011.84","volume":"31","author":"MT Wyss","year":"2011","unstructured":"Wyss MT, Magistretti PJ, Buck A, Weber B. Labeled acetate as a marker of astrocytic metabolism. J Cereb Blood Flow Metab. 2011;31(8):1668\u201374.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2-3","key":"1257_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico SL, Cassell MD, Narayanan NS. The vulnerable Ventral Tegmental Area in Parkinson\u2019s disease. Basal Ganglia. 2015;5(2\u20133):51\u20135.","journal-title":"Basal Ganglia"},{"issue":"9","key":"1257_CR74","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"EL Jacob","year":"2010","unstructured":"Jacob EL, Gatto NM, Thompson A, Bordelon Y, Ritz B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16(9):576\u201381.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"1257_CR75","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/ene.12197","volume":"20","author":"CH Lin","year":"2013","unstructured":"Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH. Preceding pain symptoms and Parkinson\u2019s disease: a nationwide population-based cohort study. Eur J Neurol. 2013;20(10):1398\u2013404.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1257_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060378","volume":"8","author":"AW Oaks","year":"2013","unstructured":"Oaks AW, Frankfurt M, Finkelstein DI, Sidhu A. Age-dependent effects of A53T Alpha-Synuclein on behavior and dopaminergic function. PLoS ONE. 2013;8(4):e60378.","journal-title":"PLoS ONE"},{"issue":"1","key":"1257_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2009.11.020","volume":"208","author":"I Branchi","year":"2010","unstructured":"Branchi I, D\u2019Andrea I, Armida M, Carnevale D, Ajmone-Cat MA, P\u00e8zzola A, et al. Striatal 6-OHDA lesion in mice: investigating early neurochemical changes underlying Parkinson\u2019s disease. Behav Brain Res. 2010;208(1):137\u201343.","journal-title":"Behav Brain Res"},{"key":"1257_CR78","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbi.2015.04.009","volume":"48","author":"C Murray","year":"2015","unstructured":"Murray C, Griffin \u00c9W, O\u2019Loughlin E, Lyons A, Sherwin E, Ahmed S, et al. Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C. Brain Behav Immun. 2015;48:274\u201386.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1257_CR79","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2443.2001.00448.x","volume":"6","author":"Y Mitani","year":"2001","unstructured":"Mitani Y, Takaoka A, Kim SH, Kato Y, Yokochi T, Tanaka N, et al. Cross talk of the interferon-alpha\/beta signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells. 2001;6(7):631\u201340.","journal-title":"Genes Cells"},{"issue":"10","key":"1257_CR80","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41419-020-03072-x","volume":"11","author":"X-f He","year":"2020","unstructured":"He X-f, Xu J-h, Li G, Li M-y, Li L-l, Pei Z, et al. NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer\u2019s disease. Cell Death Dis. 2020;11(10):849.","journal-title":"Cell Death Dis"},{"key":"1257_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis. 2017;107:41\u201356.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1257_CR82","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","volume":"36","author":"L Raz","year":"2016","unstructured":"Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab. 2016;36(1):172\u201386.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"1257_CR83","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s11064-004-6881-1","volume":"29","author":"M Su","year":"2004","unstructured":"Su M, Hu H, Lee Y, D\u2019Azzo A, Messing A, Brenner M. Expression specificity of GFAP transgenes. Neurochem Res. 2004;29(11):2075\u201393.","journal-title":"Neurochem Res"},{"issue":"6","key":"1257_CR84","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.neuron.2016.11.030","volume":"92","author":"R Srinivasan","year":"2016","unstructured":"Srinivasan R, Lu T-Y, Chai H, Xu J, Huang BS, Golshani P, et al. New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes in situ and in vivo. Neuron. 2016;92(6):1181\u201395.","journal-title":"Neuron"},{"key":"1257_CR85","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpsychires.2014.04.002","volume":"55","author":"SA Giusti","year":"2014","unstructured":"Giusti SA, Vercelli CA, Vogl AM, Kolarz AW, Pino NS, Deussing JM, et al. Behavioral phenotyping of Nestin-Cre mice: Implications for genetic mouse models of psychiatric disorders. J Psychiatr Res. 2014;55:87\u201395.","journal-title":"J Psychiatr Res"},{"key":"1257_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1480438","volume":"15","author":"DW Sirkis","year":"2024","unstructured":"Sirkis DW, Oddi AP, Jonson C, Bonham LW, Hoang PT, Yokoyama JS. The role of interferon signaling in neurodegeneration and neuropsychiatric disorders. Front Psychiatry. 2024;15:1480438.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1257_CR87","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.celrep.2018.09.003","volume":"25","author":"C Chhatbar","year":"2018","unstructured":"Chhatbar C, Detje CN, Grabski E, Borst K, Spanier J, Ghita L, et al. Type I interferon receptor signaling of neurons and astrocytes regulates microglia activation during viral encephalitis. Cell Rep. 2018;25(1):118-29.e4.","journal-title":"Cell Rep"},{"issue":"4","key":"1257_CR88","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01783-21","volume":"96","author":"CK Hayes","year":"2022","unstructured":"Hayes CK, Giraldo D, Wilcox DR, Longnecker R. The astrocyte type I interferon response is essential for protection against Herpes Simplex encephalitis. J Virol. 2022;96(4):e0178321.","journal-title":"J Virol"},{"issue":"1","key":"1257_CR89","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1038\/s41467-023-37698-0","volume":"14","author":"N Chotiwan","year":"2023","unstructured":"Chotiwan N, Rosendal E, Willekens SMA, Schexnaydre E, Nilsson E, Lindqvist R, et al. Type I interferon shapes brain distribution and tropism of tick-borne flavivirus. Nat Commun. 2023;14(1):2007.","journal-title":"Nat Commun"},{"issue":"1","key":"1257_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-025-00545-4","volume":"9","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Ma J, Niu J. Post-marketing safety signals of anifrolumab in systemic lupus erythematosus: a pharmacovigilance study based on FAERS. BMC Rheumatol. 2025;9(1):90.","journal-title":"BMC Rheumatol"},{"key":"1257_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49930","volume":"8","author":"C Nehammer","year":"2019","unstructured":"Nehammer C, Ejlerskov P, Gopal S, Handley A, Ng L, Moreira P, et al. Interferon-\u03b2-induced miR-1 alleviates toxic protein accumulation by controlling autophagy. Elife. 2019;8:e49930.","journal-title":"Elife"},{"issue":"3","key":"1257_CR92","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mds.26513","volume":"31","author":"AP Gatt","year":"2016","unstructured":"Gatt AP, Duncan OF, Attems J, Francis PT, Ballard CG, Bateman JM. Dementia in Parkinson\u2019s disease is associated with enhanced mitochondrial complex I deficiency. Mov Disord. 2016;31(3):352\u20139.","journal-title":"Mov Disord"},{"issue":"1","key":"1257_CR93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bpa.12474","volume":"28","author":"P Garcia-Esparcia","year":"2018","unstructured":"Garcia-Esparcia P, Koneti A, Rodr\u00edguez-Oroz MC, Gago B, Del Rio JA, Ferrer I. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson\u2019s disease and Parkinson\u2019s disease with dementia. Brain pathology (Zurich, Switzerland). 2018;28(1):43\u201357.","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"6","key":"1257_CR94","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity. 2016;44(6):1325\u201336.","journal-title":"Immunity"},{"issue":"6","key":"1257_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02649-13","volume":"88","author":"JD Burke","year":"2014","unstructured":"Burke JD, Platanias LC, Fish EN. Beta interferon regulation of glucose metabolism is PI3K\/Akt dependent and important for antiviral activity against Coxsackievirus B3. J Virol. 2014;88(6):3485.","journal-title":"J Virol"},{"issue":"1","key":"1257_CR96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.316","volume":"95","author":"NR Sibson","year":"1998","unstructured":"Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A. 1998;95(1):316.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1257_CR97","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jcbfm.2012.212","volume":"33","author":"LH Nilsen","year":"2013","unstructured":"Nilsen LH, Rae C, Ittner LM, G\u00f6tz J, Sonnewald U. Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation. J Cereb Blood Flow Metab. 2013;33(5):684\u201391.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"1257_CR98","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00415-008-0885-8","volume":"255","author":"N Ibarretxe-Bilbao","year":"2008","unstructured":"Ibarretxe-Bilbao N, Ram\u00edrez-Ruiz B, Tolosa E, Mart\u00ed MJ, Valldeoriola F, Bargall\u00f3 N, et al. Hippocampal head atrophy predominance in Parkinson\u2019s disease with hallucinations and with dementia. J Neurol. 2008;255(9):1324\u201331.","journal-title":"J Neurol"},{"issue":"12","key":"1257_CR99","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150\u20137.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1257_CR100","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/jnnp.2006.098079","volume":"77","author":"SA Molloy","year":"2006","unstructured":"Molloy SA, Rowan EN, O\u2019Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(12):1323\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1257_CR101","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2017.02.007","volume":"39","author":"M Fabbri","year":"2017","unstructured":"Fabbri M, Coelho M, Guedes LC, Chendo I, Sousa C, Rosa MM, et al. Response of non-motor symptoms to levodopa in late-stage Parkinson\u2019s disease: results of a levodopa challenge test. Parkinsonism Relat Disord. 2017;39:37\u201343.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"1257_CR102","doi-asserted-by":"publisher","first-page":"778","DOI":"10.31128\/AJGP-05-22-6438","volume":"51","author":"L Williams","year":"2022","unstructured":"Williams L, Qiu J, Waller S, Tsui D, Griffith J, Fung VSC. Challenges in managing late-stage Parkinson\u2019s disease: practical approaches and pitfalls. Aust J Gen Pract. 2022;51(10):778\u201385.","journal-title":"Aust J Gen Pract"},{"issue":"9","key":"1257_CR103","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jamaneurol.2019.1368","volume":"76","author":"WY Lin","year":"2019","unstructured":"Lin WY, Lin MS, Weng YH, Yeh TH, Lin YS, Fong PY, et al. Association of antiviral therapy with risk of Parkinson disease in patients with chronic Hepatitis C virus infection. JAMA Neurol. 2019;76(9):1019\u201327.","journal-title":"JAMA Neurol"},{"issue":"35","key":"1257_CR104","doi-asserted-by":"publisher","first-page":"14231","DOI":"10.1523\/JNEUROSCI.5812-12.2013","volume":"33","author":"Y Liu","year":"2013","unstructured":"Liu Y, Carlsson R, Ambjorn M, Hasan M, Badn W, Darabi A, et al. PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients. J Neurosci. 2013;33(35):14231\u201345.","journal-title":"J Neurosci"},{"issue":"9","key":"1257_CR105","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ni.2667","volume":"14","author":"NA de Weerd","year":"2013","unstructured":"de Weerd NA, Vivian JP, Nguyen TK, Mangan NE, Gould JA, Braniff S-J, et al. Structural basis of a unique interferon-\u03b2 signaling axis mediated via the receptor IFNAR1. Nat Immunol. 2013;14(9):901\u20137.","journal-title":"Nat Immunol"},{"issue":"9","key":"1257_CR106","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.tins.2019.06.003","volume":"42","author":"BS Khakh","year":"2019","unstructured":"Khakh BS. Astrocyte-neuron interactions in the striatum: insights on identity, form, and function. Trends Neurosci. 2019;42(9):617\u201330.","journal-title":"Trends Neurosci"},{"issue":"3","key":"1257_CR107","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","volume":"95","author":"H Chai","year":"2017","unstructured":"Chai H, Diaz-Castro B, Shigetomi E, Monte E, Octeau JC, Yu X, et al. Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron. 2017;95(3):531-49.e9.","journal-title":"Neuron"},{"issue":"D1","key":"1257_CR108","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-026-01257-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:01:55Z","timestamp":1780329715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-026-01257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1186\/s12929-026-01257-8","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with Danish ethical standards in compliance with Directive 2010\/63\/EU, under ethical permission licenses 2013-15-2934-00807 and 2018-15-0201-01572, and are in adherence with ARRIVE guidelines (v2.0). As the study does not include a clinical trial, consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}